Kessel, Christoph and Rossig, Claudia and Abken, Hinrich (2025) Weal and woe of interleukin-18 in the T cell therapy of cancer. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 13 (1): e010545. ISSN 2051-1426
Full text not available from this repository. (Request a copy)Abstract
Chimeric antigen receptor (CAR) T cell therapy of solid cancer remains below expectations; adding cytokine help through IL-18 has shown remarkable efficacy in first clinical trials. As IL-18 is also a powerful driver of hyperinflammatory conditions, we discuss to what extent unleashing IL-18 is a double-edged sword in CAR T cell therapies.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | MACROPHAGE ACTIVATION SYNDROME; IFN-GAMMA; DISEASE; IL-18; AUGMENTATION; RUXOLITINIB; EMAPALUMAB; CHILDREN; MODELS |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 11 Nov 2026 06:30 |
| Last Modified: | 11 Nov 2026 06:30 |
| URI: | https://pred.uni-regensburg.de/id/eprint/66388 |
Actions (login required)
![]() |
View Item |

